241 related articles for article (PubMed ID: 15492815)
21. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19.
Constância M; Dean W; Lopes S; Moore T; Kelsey G; Reik W
Nat Genet; 2000 Oct; 26(2):203-6. PubMed ID: 11017078
[TBL] [Abstract][Full Text] [Related]
22. Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma.
Dammann RH; Kirsch S; Schagdarsurengin U; Dansranjavin T; Gradhand E; Schmitt WD; Hauptmann S
Int J Oncol; 2010 Jan; 36(1):171-9. PubMed ID: 19956846
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
[TBL] [Abstract][Full Text] [Related]
25. Paternal imprints can be established on the maternal Igf2-H19 locus without altering replication timing of DNA.
Cerrato F; Dean W; Davies K; Kagotani K; Mitsuya K; Okumura K; Riccio A; Reik W
Hum Mol Genet; 2003 Dec; 12(23):3123-32. PubMed ID: 14532328
[TBL] [Abstract][Full Text] [Related]
26. Deletions and rearrangements of the H19/IGF2 enhancer region in patients with Silver-Russell syndrome and growth retardation.
Grønskov K; Poole RL; Hahnemann JM; Thomson J; Tümer Z; Brøndum-Nielsen K; Murphy R; Ravn K; Melchior L; Dedic A; Dolmer B; Temple IK; Boonen SE; Mackay DJ
J Med Genet; 2011 May; 48(5):308-11. PubMed ID: 21278389
[TBL] [Abstract][Full Text] [Related]
27. Dynamic readjustment of parental methylation patterns of the 5'-flank of the mouse H19 gene during in vitro organogenesis.
Liang L; Kanduri C; Pilartz M; Svensson K; Song JH; Wentzel P; Eriksson U; Ohlsson R
Int J Dev Biol; 2000 Oct; 44(7):785-90. PubMed ID: 11128572
[TBL] [Abstract][Full Text] [Related]
28. CTCF binding is not the epigenetic mark that establishes post-fertilization methylation imprinting in the transgenic H19 ICR.
Matsuzaki H; Okamura E; Fukamizu A; Tanimoto K
Hum Mol Genet; 2010 Apr; 19(7):1190-8. PubMed ID: 20047949
[TBL] [Abstract][Full Text] [Related]
29. Methylation status of imprinting centers for H19/IGF2 and SNURF/SNRPN in primate embryonic stem cells.
Mitalipov S; Clepper L; Sritanaudomchai H; Fujimoto A; Wolf D
Stem Cells; 2007 Mar; 25(3):581-8. PubMed ID: 17170068
[TBL] [Abstract][Full Text] [Related]
30. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
Sparago A; Cerrato F; Vernucci M; Ferrero GB; Silengo MC; Riccio A
Nat Genet; 2004 Sep; 36(9):958-60. PubMed ID: 15314640
[TBL] [Abstract][Full Text] [Related]
31. Acquisition of the H19 methylation imprint occurs differentially on the parental alleles during spermatogenesis.
Davis TL; Trasler JM; Moss SB; Yang GJ; Bartolomei MS
Genomics; 1999 May; 58(1):18-28. PubMed ID: 10331941
[TBL] [Abstract][Full Text] [Related]
32. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.
Hark AT; Schoenherr CJ; Katz DJ; Ingram RS; Levorse JM; Tilghman SM
Nature; 2000 May; 405(6785):486-9. PubMed ID: 10839547
[TBL] [Abstract][Full Text] [Related]
33. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression.
Dejeux E; Olaso R; Dousset B; Audebourg A; Gut IG; Terris B; Tost J
Endocr Relat Cancer; 2009 Sep; 16(3):939-52. PubMed ID: 19502451
[TBL] [Abstract][Full Text] [Related]
35. The 3' portion of the mouse H19 Imprinting-Control Region is required for proper tissue-specific expression of the Igf2 gene.
Hagège H; Nasser R; Weber M; Milligan L; Aptel N; Jacquet C; Drewell RA; Dandolo L; Surani MA; Cathala G; Forné T
Cytogenet Genome Res; 2006; 113(1-4):230-7. PubMed ID: 16575185
[TBL] [Abstract][Full Text] [Related]
36. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer.
Takai D; Gonzales FA; Tsai YC; Thayer MJ; Jones PA
Hum Mol Genet; 2001 Nov; 10(23):2619-26. PubMed ID: 11726548
[TBL] [Abstract][Full Text] [Related]
37. A complex duplication created by gene targeting at the imprinted H19 locus results in two classes of methylation and correlated Igf2 expression phenotypes.
Reed MR; Huang CF; Riggs AD; Mann JR
Genomics; 2001 Jun; 74(2):186-96. PubMed ID: 11386755
[TBL] [Abstract][Full Text] [Related]
38. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation.
Jelinic P; Stehle JC; Shaw P
PLoS Biol; 2006 Oct; 4(11):e355. PubMed ID: 17048991
[TBL] [Abstract][Full Text] [Related]
39. Examination of IGF2 and H19 loss of imprinting in bladder cancer.
Byun HM; Wong HL; Birnstein EA; Wolff EM; Liang G; Yang AS
Cancer Res; 2007 Nov; 67(22):10753-8. PubMed ID: 18006818
[TBL] [Abstract][Full Text] [Related]
40. Establishment of functional imprinting of the H19 gene in human developing placentae.
Jinno Y; Ikeda Y; Yun K; Maw M; Masuzaki H; Fukuda H; Inuzuka K; Fujishita A; Ohtani Y; Okimoto T
Nat Genet; 1995 Jul; 10(3):318-24. PubMed ID: 7670470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
